Regulatory and governance gaps for human genome editing in Mexico

Trends Biotechnol. 2023 Dec 20:S0167-7799(23)00335-9. doi: 10.1016/j.tibtech.2023.11.013. Online ahead of print.

Abstract

Mexico has the in-house technical and regulatory capacity to undertake human genome editing (HGE) governance. However, its regulatory framework must be reformed to be more targeted and govern the application of any emerging HGE technologies, leaving no room for unethical or unsafe practices for reproductive purposes.

Keywords: Mexico; germline; human genome editing; reform options; regulatory framework.